Watchlist Price Alert

Syndax Pharmaceuticals In... (SNDX)

NASDAQ: SNDX · Real-Time Price · USD

9.79

-0.20 (-2.00%)

At close: Jun 17, 2025, 2:21 PM

Syndax Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	154.08M	295.39M	74.36M	221.97M	115.24M	24.61M	33.77M	35.17M	23.84M
Short-Term Investments	418.8M	282.19M	410.04M	217.97M	177.82M	35.17M	47.14M	94.81M	81.49M
Long-Term Investments	119.52M	29.83M	5.47M	n/a	115K	115K	n/a	3.25M	n/a
Other Long-Term Assets	217K	680K	9.44M	n/a	1.15M	82K	219K	231K	243K
Receivables	11.24M	1.23M	4.06M	429K	175K	116K	253K	377K	306K
Inventory	366K	n/a	-4.25M	7.65M	5.28M	1.68M	1.05M	-1.44M	2.41M
Other Current Assets	10.64M	63K	8.79M	7.27M	456K	2.06M	1.79M	1.29M	615K
Total Current Assets	603.06M	580.88M	481.27M	448.4M	298.86M	62.33M	83.35M	133.44M	108.51M
Property-Plant & Equipment	2.02M	1.5M	1.06M	1.26M	482K	997K	373K	267K	260K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	121.76M	32M	15.96M	1.26M	1.75M	1.19M	592K	3.74M	503K
Total Assets	724.82M	612.88M	497.24M	449.66M	300.61M	63.52M	83.94M	137.19M	109.01M
Account Payables	11.63M	9.96M	4.35M	5.67M	3.51M	6.18M	1.44M	2.23M	2.38M
Deferred Revenue	n/a	n/a	n/a	12.76M	1.52M	1.52M	1.52M	1.57M	1.22M
Short-Term Debt	12.12M	n/a	n/a	n/a	2.29M	n/a	n/a	n/a	n/a
Other Current Liabilities	79.33M	35.92M	18.33M	1.89M	8.03M	7.39M	10.35M	9.6M	5.13M
Total Current Liabilities	103.55M	58.1M	29.07M	20.68M	18.87M	18.37M	16.11M	15.8M	10.37M
Long-Term Debt	n/a	n/a	n/a	19.89M	17.83M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	331.56M	n/a	n/a	n/a	1K	5K	136K	310K	288K
Total Long-Term Liabilities	333.14M	588K	722K	20.61M	29.55M	13.56M	14.79M	17.07M	14.51M
Total Liabilities	436.69M	58.68M	29.79M	41.29M	48.42M	31.93M	30.89M	32.87M	24.87M
Total Debt	345.74M	1.64M	1.16M	20.97M	20.54M	897K	n/a	n/a	n/a
Common Stock	9K	8K	7K	6K	5K	3K	2K	2K	2K
Retained Earnings	-1.22B	-902.4M	-693.04M	-543.7M	-568.63M	-495.47M	-439.42M	-366.11M	-305.29M
Comprehensive Income	163K	218K	-806K	45K	-4K	n/a	-25K	-143K	56K
Shareholders Equity	288.12M	554.2M	467.45M	408.37M	252.19M	31.6M	53.05M	104.32M	84.14M
Total Investments	538.32M	312.02M	406.92M	217.97M	177.82M	35.17M	47.14M	98.05M	81.49M